MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$5,506,000
EPS
-$6.95
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
NaN 0* NaN 0
Cost of revenues
NaN 0* NaN 0
Gross profit
NaN 0 NaN 0
Gain on lease termination
NaN 0 NaN NaN
Research and development
1,915,000 676,000 1,035,000 1,136,000
General and administrative
1,631,000 1,419,000 958,000 1,365,000
Impairment of goodwill
2,044,000 NaN NaN NaN
Total operating expenses
5,590,000 2,095,000 1,993,000 2,501,000
Loss from operations
-5,590,000 -2,095,000 -1,993,000 -2,501,000
Change in fair value of convertible notes
NaN 0* NaN NaN
Change in fair value to bridge notes derivative liability
NaN 0* NaN NaN
Change in fair value of contingent consideration
NaN 0* NaN 0
Forward Sales Contract Expense
NaN 1,495,750* NaN -512,000
Other income, net
NaN 479,000 -6,000 -123,000
Change in fair value of warrant liabilities
NaN 500* NaN 0
Losss Gaines On Extinguishment Of Debt
NaN -1,402,000* 734,000 NaN
Interest income
NaN 20,750* NaN NaN
Interest income, net
44,000 -63,000 31,000 0
Total other income (expense), net
44,000 530,000 759,000 -635,000
Loss before income taxes
-5,546,000 -1,565,000 -1,234,000 -3,136,000
Benefit (provision) for income taxes
-40,000 -62,000 6,000 3,000
Net loss
-5,506,000 -1,503,000 -1,240,000 -3,139,000
Series a preferred stock dividend
NaN 8,000 NaN 8,000
Net loss attributable to common stockholders
NaN -1,511,000 -1,240,000 -3,147,000
Basic EPS
-6.95 -0.24 -0.15 -0.61
Diluted EPS
-6.95 -0.24 -0.15 -0.61
Basic Average Shares
792,000 6,307,000* 8,226,000 5,179,000
Diluted Average Shares
792,000 6,307,000* 8,226,000 5,179,000
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$5,506,000 (32.87%↑ Y/Y)Benefit (provision) forincome taxes-$40,000 (-600.00%↓ Y/Y)Interest income, net$44,000 (780.00%↑ Y/Y)Loss before incometaxes-$5,546,000 (32.32%↑ Y/Y)Total other income(expense), net$44,000 (100.81%↑ Y/Y)Loss from operations-$5,590,000 (-104.76%↓ Y/Y)Total operatingexpenses$5,590,000 (104.76%↑ Y/Y)Impairment of goodwill$2,044,000 Research and development$1,915,000 (46.29%↑ Y/Y)General andadministrative$1,631,000 (14.78%↑ Y/Y)

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Inc. (ERNA)